1. Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer
   Karthik Reddy Kami Reddy et al, 2022, Metabolites CrossRef
2. Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma
   Lina Wang et al, 2017, Oncotarget CrossRef
3. Metabolomics of lung cancer: Analytical platforms and their applications
   Hamada A. A. Noreldeen et al, 2020, Journal of Separation Science CrossRef
4. Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues
   Eva Cífková et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
5. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA
   Matt R. Paul et al, 2016, BMC Genomics CrossRef
6. Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
   Jia Xu et al, 2022, BioMed Research International CrossRef
7. Metabolic Perturbation Score-Based Mass Spectrometry Imaging Spatially Resolves a Functional Metabolic Response
   Xiaowei Song et al, 2023, Analytical Chemistry CrossRef
8. Comparable Plasma Lipid Changes in Patients with High-Grade Cervical Intraepithelial Neoplasia and Patients with Cervical Cancer
   Miso Nam et al, 2021, Journal of Proteome Research CrossRef
9. Metabolite profiling for biomarkers in Schistosoma haematobium infection and associated bladder pathologies
   Adewale S. Adebayo et al, 2018, PLOS Neglected Tropical Diseases CrossRef
10. A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
    Sandra Kannampuzha et al, 2023, Vaccines CrossRef
11. In-vitro metabolomics to evaluate toxicity of particulate matter under environmentally realistic conditions
    Francisco Sánchez-Soberón et al, 2018, Chemosphere CrossRef
12. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer
    Johannes F. Fahrmann et al, 2016, Cancer Biomarkers CrossRef
13. 3-O-Acetyl-11-keto- -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
    Wan Li et al, 2020, Acta Pharmaceutica Sinica B CrossRef
14. Targeting Phospholipid Metabolism in Cancer
    Menglin Cheng et al, 2016, Frontiers in Oncology CrossRef
15. Bilayer Forming Phospholipids as Targets for Cancer Therapy
    Celine Stoica et al, 2022, International Journal of Molecular Sciences CrossRef
16. In situ metabolite and lipid analysis of GluN2D−/− and wild-type mice after ischemic stroke using MALDI MSI
    William T. Andrews et al, 2020, Analytical and Bioanalytical Chemistry CrossRef
17. Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells
    Érica Aparecida de Oliveira et al, 2017, Pharmacological Research CrossRef